Skip to content

Prospective cohort study on constructing a predictive model for the outcome of cancer-related pain in Shenzhen based on multi-sensor technology and machine learning, and exploring the early intervention of acupuncture for pain relief

Prospective cohort study on constructing a predictive model for the outcome of cancer-related pain in Shenzhen based on multi-sensor technology and machine learning, and exploring the early intervention of acupuncture for pain relief

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000225
Enrollment
Unknown
Registered
2024-08-13
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Pain

Interventions

Cancer pain group:acupuncture

Sponsors

Guangzhou University of Traditional Chinese Medicine Shenzhen Hospital (Futian)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1: After pathological diagnosis, the patient is diagnosed with malignant tumor and is expected to survive for more than 3 months 2: The numerical rating scale (NRS) score for pain is = 4 points and/or the number of episodes of pain is = 3 times per day 3: ECOG score of 0-3 and KPS score of = 50 in the Eastern United States

Exclusion criteria

Exclusion criteria: 1 Patients with communication barriers or impaired consciousness 2 Patients unwilling to receive acupuncture techniques for analgesia 3 Patients with mental disorders 4 Patients with severe infections or organ dysfunction such as liver and kidney 5 Patients with previous nervous system diseases such as epilepsy, Parkinson's disease, cerebral stroke, or those with implanted electronic devices or metal implants that are difficult to remove and may affect electroencephalogram (EEG) observations 6 Pregnant women, lactating women, and those who have plans to conceive in the next six months

Design outcomes

Primary

MeasureTime frame
NRS;

Secondary

MeasureTime frame
frequency of breakthrough pain;equivalent morphine dosage;

Countries

china

Contacts

Public Contactyufeng Xie

Shenzhen Hospital of Guangzhou University of Chinese Medicine (Futian)

714732618@qq.com+86 137 6038 7089

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026